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Cytokines in cyst fluids from polycystic kidneys. We sought evidence
of cytokine presence and interleukin-1f3 (IL-113) bioactivity in 104
aerobic culture negative cyst fluids (CFs) from 13 kidneys of 13 patients
with symptomatic normal to end-stage autosomal dominant polycystic
kidney disease (ADPKD), ELISAs were used to detect IL-1J3, interleu-
kin-2 (IL-2), tumor necrosis factor alpha (TNFo) and stromelysin.
Prostaglandin E2 (PGE2) was detected by radioimmunoassay. IL-113
was present in 65 of 94 (<20 to 419 pg/mI, TNFa in 54 of 75 (<10 to 73
pg/mi), stromelysin in 18 of 23 (<1.0 to 56 ng/ml), IL-2 in 7 of 23 (0.1 to
1.3 nglml) and PGE2 in 9 of 10 fluids (0.03 to 0.49 ng/ml). Of 51 fluids
with immunoreactive IL-lf3, 36 were mitogenic for thymocytes. IL-1/3
concentrations correlated directly with those of IL-2; IL-113 presence
was associated with higher stimulation indices, higher mean concentra-
tions of TNFa, IL-2, stromelysin, and PGE2, and with positive endo-
toxin assays, suggesting activation of the cytokine cascade in vivo.
Cytokine, stromelysin and PGE2 concentrations did not correlate with
sodium or non-sodium solute concentrations, nor with CF blood,
osmolality, or endotoxin activity, indicating that differences in concen-
trations among fluids could not be explained by differences in water
content. These data identify cytokines as candidate contributors to the
morbidity and pathogenesis of ADPKD.
Cytokines are pluripotent proteins. They are produced by
nucleated cells in response to inflammatory, immunologic, or
physical injury [1, 2]. They have been implicated in diverse
disease states including endotoxemia [3], bacterial meningitis
[41, acquired immune deficiency syndrome [5], multiple sclero-
sis [6], Graves' disease [7], vasculitis [8], periodontitis [9],
rheumatoid arthritis [10, 111 and glomerulonephritis [12].
The possibility that cytokines are present and active in the
kidneys of autosomal dominant polycystic kidney disease
(ADPKD) heretofore has not been considered. It was suggested
to us by several observations: First, cytokines are associated
with tissue remodeling [13]. The polycystic kidney displays
extensively remodeled nephrons [14]. Second, endotoxin pro-
vokes explosive cyst formation in the kidneys of germfree rats
fed nordihydroguaiaretic acid [151. Cytokines mediate effects of
endotoxin [1—3]. Third, certain cytokines are mitogenic for
thymocytes from the C3H/HeJ mouse [16, 17]. Some fluids from
polycystic kidneys cause C3H/HeJ mouse thymocytes to pro-
liferate [181.
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Demonstrations of cytokine presence and bioactivity in poly-
cystic kidneys logically must precede any consideration of
whether or how these substances might influence the evolution
of the disease. We have assayed fluids from polycystic kidneys
for mitogenicity and for IL-113, tumor necrosis factor alpha
(TNFa), interleukin-2 (IL-2), stromelysin, and prostaglandin E2
(PGE2). We have found that most fluids contain one or more of
these substances. Analyses of our data suggest that some of the
IL-i p detected immunologically in vitro had been biologically
active in vivo.
Methods
Cyst fluids
Fluids from 13 in-situ kidneys of 13 patients with normal to
end-stage renal function were analyzed (Table 1). All patients
were symptomatic from ADPKD and were undergoing thera-
peutic cyst decompression [19], nephrectomy or biopsy. A total
of 104 aerobic culture negative cyst aspirates and two paraop-
erative sera and urines (Patients 2 and 5) were available. After
aspiration and culture, fluids were centrifuged at 3000 rpm for
15 minutes. Cell-free supernatants were aliquoted and stored at
—20° to —70°C. Studies were performed on 100 jsl aliquots
thawed for 30 minutes at room temperature on the day of
analysis.
Immunoassays
Commercial sandwich ELISAs were used to detect IL-1/3
(Cistron Biotechnology, Pine Brook, New Jersey, USA), TNFa
(T Cell Sciences, Cambridge, Massachusetts, USA), and IL-2
(Genzyme Corp., Boston, Massachusetts, USA). According to
their manufacturers, these assays are highly specific and accu-
rately measure concentrations above the following limits: IL-I p
> 20 pg/mI; TNFa> 10 pg/mI; IL-2 > 0.3 nglml. Stromelysin
was quantitated by an ELISA developed and performed in the
laboratories of MW Lark and LA Walakovits (Merck Sharp &
Dohme Research Laboratories, Division of Merck & Co., Inc.,
Rahway, New Jersey, USA).
Bioassays
Fluids were assayed for bioactivity at 1:32 dilutions. Their
abilities to enhance 3H-thymidine incorporation by Con A-stim-
ulated D-10 T-helper cells [16, 17] or (for 16 fluids) PHA-
stimulated C3H/HeJ mouse thymocytes [20] were determined.
Results were expressed in terms of a stimulation index—the
ratio of isotope incorporated into thymocytes in the presence
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Table 1. Patient demography
Patient Age Occasion of [Creatinine] No. of
no. Gender years aspiration
—
mg/dl fluids
1 F 43 Pain relief 2.5 35
2 M 38 Pain relief 6 19
3 M 46 Renal biopsy 5.6 14
4 M 39 Prenephrectomy 1.3 13
5 F 31 Pain relief 0.8 8
6 M 54 Pain relief 4.9 5
7 M 42 Pain relief 2.4 2
8 M 42 Progressing azotemia 5.2 2
9 F 35 Pain relief 0.9 2
10 M 39 Pain relief 3.4 1
11 M 32 Pain relief Dialysis 1
12 M 62 Pain relief Dialysis I
13 F 36 Pain relief 2.9 1
versus in the absence of cyst fluid. A mitogenic fluid arbitrarily
was defined as one whose stimulation index was greater than
unity. A fluid was considered non-mitogenic if its stimulation
index was unity or below.
Endotoxin
The Limulus amebocyte lysate test (E-TOXATE®, Sigma
Chemical Co., St. Louis, Missouri, USA) was performed ac-
cording to the manufacturer's instructions in order to detect the
presence (>0.005 ng!ml) or absence (<0.005 ng/ml) of endo-
toxin, orto demonstrate presence of active endotoxin inhibitors
in cyst fluids and one urine (Patient 2).
PGE2
PGE2 was measured by radioimmunoassay (DuPont Prosta-
glandin E2 [1251] RIA Kit, E.I. DuPont de Nemours & Co.,
Boston, Massachusetts, USA).
Solute analyses
Cyst fluid osmolalities, and concentrations of sodium and
creatinine were measured by commercial laboratory (Clinical
Pathology Laboratory, University of New Mexico Hospital,
Albuquerque, New Mexico, USA). The concentration of non-
sodium solute (mOsm/kg water) was calculated by subtracting
twice the sodium concentration (in mEq/liter) from total osmo-
lality.
Blood
A commercial dipstick was used to detect and semiquantitate
cyst fluid concentrations of blood (Chemstrip® 9, Boehringer
Mannheim Corp., Indianapolis, Indiana, USA). Results were
recordedas0=none;l+ = <lO;2+ = l0-50;3+ =50-250;and
4+ = >250 erythrocytes/pi.
Statistics
Routine statistical analyses were performed by computer
(Stat View 512+, Brainpower Inc., Calabasas, California,
USA). A P value of <0.05 was accepted as significant.
Results
Cytokines
Immunoreactive IL-1/3 was detected in 65 of 94 fluids (69%),
TNFa in 54 of 75 fluids (72%), and IL-2 in 7 of 23 fluids (30%)
(Figs. 1 and 2). Concentrations varied. Those of IL-l/3 ex-
ceeded 20 pglml in 62% and 100 pglml in 25% of the 65
IL-l/3-positive fluids (Fig. IA). TNFa concentrations were
greater than 10 pg/mI in 57% and 50 pg/mI in 19% of the 54
TNFa-positive fluids (Fig. lB). Concentrations of IL-2 were
equal to or greater than 0.3 ng/ml in 6 (26%) of the IL-2 positive
fluids (Fig. 1C).
The distributions of monokine-positive and mitogenic fluids
varied among patients (Fig. 2). Immunoreactive IL-1f3 was
detected in some fluids of most kidneys (Fig. 2A). Immunore-
active TNFa was present in some fluids of every kidney,
usually in concentrations above 11 pg/mI (Fig. 2B). The propor-
tions of fluids that contained IL- 1/3 or TNFa varied significantly
from kidney to kidney (Patients I to 6, Fig. 2) (ANOVA; P <
0.05).
a Paraoperative serum and urine available
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Fig. 1. Concentrations of immunoreactive
IL-/p (A), TNFa (B), and IL-2 (C), ranked in
order of ascending magnitudes.
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IL-1/3
present
IL-1$
absent Total
Mitogenic 36 10 46
Not mitogenic 15 13 28
Total 51 23 74
Mitogenicity
Mitogenicity and IL-1f3 were not invariably associated. Both
were assessed in 74 fluids (Table 2). Most mitogenic fluids (Fig.
2C) contained immunoreactive IL-1/3. Ten fluids were mitogen-
ic but did not contain IL-1$. Fifteen fluids contained IL-i$ but
were not mitogenic. None of the fluids from Patients 4 and 6
was mitogenic (Fig. 2C). Mean (± SEM) stimulation indices
were highest for fluids containing both IL-113 and IL-2 (7.8
5.9), intermediate for fluids containing one monokine (4.5 3.6)
and lowest for those containing neither IL-i/3 nor IL-2 (0.9
0.2). The differences approached but did not achieve statistical
significance (Student's t and Kruskall Wallis tests).
Endotoxin
Of 63 fluids tested, eight were positive while 32 were negative
for endotoxin activity. The remaining 23 fluids inhibited the
gellation response when exogenous endotoxin was added to
them, indicating presence of inhibitors. Endotoxin-containing
cysts did not segregate by patient. The mean concentrations of
monokines were higher in endotoxin-positive than in endotoxin-
negative fluids (IL-1f3: 62 23 vs. 28 9 pg/ml; TNFa: 25 10
vs. 13 9 pg/mI) but the differences did not achieve statistical
significance. The one urine tested was negative for endotoxin.
Solute concentrations
Sodium concentrations were measured in 85 fluids. They
ranged from 3 to 210 mEq/liter (Fig. 3A). Concentrations in 9
fluids were above and in 50 fluids were below the range of
sodium concentration in normal serum. Osmolalities were mea-
sured in 75 cyst fluids. They ranged from 220 to 550 mOsm/kg
water (Fig. 3B).
Stromelysin
Stromelysin was detected in at least one fluid from each of 10
kidneys. Concentrations ranged from none detected to 55
ng/ml. Concentrations exceeded 1.0 ng/ml in 18 and 10 ng/ml in
eight of the 23 fluids.
PGE2
PGE2 was detected in fluids from four of four kidneys and in
nine of the ten fluids assayed for it. Concentrations ranged from
0.01 to 0.487 ng/ml.
Blood
Blood was detected in varying concentrations in 41 of 48
fluids (Fig. 3C) from 8 of 10 kidneys.
Creatinine
Creatinine concentrations were measured in 30 fluids from 8
kidneys. They ranged from ito 113 mg/dl.
Correlations
A significant, direct correlation existed between the concen-
trations of IL-l/3 and IL-2 (y = 0.092 + 0.003x; r = 0.64; P <
0.001; Fig. 4). The higher the concentrations of IL-l$, the more
likely were fluids to contain IL-2 or stromelysin (Table 3).
Significant, indirect correlations existed between cyst fluid
sodium concentrations and those of creatinine (y 71.3 — 0.4x;
r = — 0.66; P < 0.004) and non-sodium solute (y = 288.6 —
1.8x; r —0.87; P < 0.001).
No relationship existed between the concentrations of IL-1$
and sodium (Fig. 5). No correlations were found between the
concentrations of IL-1/3 and those of TNFa, stromelysin,
sodium, creatinine, or non-sodium solute and osmolality. Nei-
ther IL-l/3 nor TNFa concentrations correlated with cyst fluid
bloods.
Means
The mean stimulation index and the mean concentrations of
IL—2, TNFs, stromelysin, and PGE2 were greater among fluids
containing immunoreactive IL- 1/3. The mean concentration of
IL-1/3 was higher in the presence of endotoxin (Table 4).
Among kidneys, cyst fluid osmolalities varied significantly
(ANOVA; P < 0.001); sodium and creatinine concentrations,
and blood contents did not.
Discussion
Immunoreactive cytokines—IL-l/3, TNFa, and IL-2—were
detected in many cyst fluids from most or all kidneys (Fig. 2).
Cytokine production generally is considered to be local and
transient [1, 2]. The presence of cytokines in renal cysts whose
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Table 2. Chi-square analysis of rnitogenic fluids in relation to their
contents of immunoreactive IL-113
Fig. 2. Prevalence of monokine-containing (A
and B) and mitogenic (C) fluids in kidneys, by
patient where 5 or more fluids were available
(Pts. I to 6) and grouped where only I or 2
fluids per patient were available (Pts. 7 to 13).
Note that some fluids with IL-113 were not
mitogenic (compare with those of patients 4
and 6, Figs. 2A vs. 2C). Abbreviation S.I. is
stimulation index,
P < 0.05 (Yates correction applied)
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fluids were sampled at presumably random points in time
suggests on-going synthesis and release, failure of degradation
[21], or the unlikely possibility of an effect of surgery. Either of
the former alternatives could represent a fundamental defect in
cytokine metabolism by the polycystic kidney.
In considering the question of bioactivity, we focused on
IL-1/3. IL-l/3 plays a central role in the cytokine network [21.
IL-l/3 is known to be released by endotoxin-stimulated macro-
phages [2]. It provokes the release of stromelysin from fibro-
blasts [13], TNFa from macrophages [51, and PGE2 from
papillary collecting duct cells [22]. It induces thymus-derived
cells to proliferate and to release IL-2 [1, 2, 16]. To establish
which fluids had bioactivity, we performed thymocyte comito-
gen assays. These assays, while not specific [20], are responsive
to IL-i [16, 17, 23]. To obtain evidence supportive of IL-1/3
bioactivity in vivo, we examined relationships between the
presence and the concentrations of IL-l/3 on the one hand and
stimulation indices, IL-2, TNFa, stromelysin, PGE2, and en-
dotoxin on the other. We reasoned that had IL-1f3 been active
in vivo, higher concentrations of these parameters should be
associated with the presence of IL-1f3.
Most mitogenic fluids contained IL-l13 (Table 2). Mitogenesis
and cytokines were not invariably associated, however (Fig.
2C). Mitogenic fluids that did not contain IL-1f3 might have
contained IL-i a or other mitogenic cytokines [20, 23]. Non-
mitogenic fluids with IL-1$ might have contained soluble inhib-
itors [24] of the monokine. We did not explore these possibili-
Analyses of relationships among endotoxin and cytokine
concentrations yielded four findings supportive of an argument
that IL-l/3 had been biologically active in vivo: (i) IL-2 concen-
trations correlated directly with those of IL-i/3 (Fig. 4) and
more fluids contained IL-2 at the higher concentrations of IL- 113
(Table 3). IL-i is known to induce T-helper cells to produce and
release IL-2 [1, 2, 16]. (ii) The number of fluids containing
stromelysin in concentrations greater than 1.0 nglml increased
as the concentration of IL-1f3 increased (Table 3). IL-i pro-
vokes the synthesis and release of stromelysin from fibroblasts
[25]. (iii) Stimulation indices were highest, albeit not signifi-
cantly so, among fluids that contained both IL- 1/3 and IL-2
(Results). IL-l and IL-2 are synergistic mitogens for T-helper
450 cells [1] (iv) The predicted effects of endotoxin and IL- 1/3
prevailed in analyses of mean indices and concentrations (Table
4). This degree of consistency with predicted outcome is
analagous to flipping six heads of a coin in six attempts on
demand, and therefore is not likely to have been fortuitous. It
might occur by chance once in 64 trials [26].
We made no effort to pinpoint origins of cytokines or stromel-
ysin. Too little is known about stromelysin in the kidney to
comment. For the monokines, however, several possibilities
exist. Monokines might enter cysts with bleeding [3] or with
filtrate, coming either from plasma or after release by mesangial
cells [27]. They might be made and released by cells that line
proximate or remote cyst walls, or by inflammatory cells in
interstitium or cyst lumen [1, 2]. Of these alternatives, the
results exclude blood, bleeding, and filtrate. Most fluids (85%)
were positive for blood. However, neither its presence nor its
semi-quantitative concentrations correlated with those of
monokines. In addition, monokines were found in cysts when
absent from blood. Of two sera, one (Patient 2) contained TNFa
(23 pg/mI) but no detectable IL-l$. Thirteen of 14 cysts in the
kidney of this male were positive for IL-1f3 (Fig. 2A). The
second serum (Patient 5) contained IL- 1/3 (229 pg/mi) but no
TNFa. Seven of eight cysts in the kidney of this female were
positive for immunoreactive TNFa (Fig. 2B). Notably, some
large cysts in polycystic kidneys do not communicate with
tubules [28]. Without communication, it is not possible for any
substance to enter with filtrate.
Nor did we identify circumstances that triggered appearance
of cytokines in cysts. Infection, intracystic endotoxin activity,
and uremia probably can be excluded. Cytokines were present
in fluids that aerobically were sterile. Admittedly, we did not
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Fig. 3. Concentrations of sodium (A),
osmolality (B), and blood (C), ranked in order
of ascending magnitudes. The relatively wide
range of osmolalities shown here is similar to
that reported for fluids aspirated from in situ
(290 to 372 mOsm/kg) [39] but not ex vivo
(286 to 290 mOsmlkg) kidneys [40, 411.
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Fig. 4. Correlation between concentrations of IL-1/3 and IL-2. A
similar relationship has been shown between IL-1$ and IL-2 in synovial
fluids from rheumatoid joints [11].
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Table 3. Frequencies with which immunoreactive IL-2 and stromelysin were present in cyst fluids , grouped according to IL-i /3 concentrations
Data are presented as means SEM.
a One tail critical value of chi-square with 2 degrees of freedom is 4.60 [38].
b NS not significant by Student's t and Kruskal-Wallis tests.
Table 4. Mean indices and concentrations ( SE) in presence and
absence of IL-113 and of IL-I /3 in fluids with and without endotoxin
IL-1$ present IL-1/3 absent
Stimulation index 10.0 1.7 5.2 ÷ 1.8
TNFa pg/mi 15.8 3.6 12.9 10.4
Interleukin-2 ng/ml 0.3 0.1 0.1 0.1
Stromelysin ng/m/ 11.3 4.1 6.8 4.3
PGE2 ag/mi 0.2 0.1 0.1 + 0.3
Endotoxin present Endotoxin absent
IL-i$ pg/mi 61.9 23.3 28.6 8,4
a Differencebetween means is significant at P < 0.05 level (Student's
t-test).
perform anaerobic or viral cultures on our fluids. It is possible
that some, but unlikely that all, monokine-positive fluids would
have cultured positively under these conditions. Some local
effect of intralumenal endotoxin is possible, but its candidacy as
a likely trigger is dubious because levels of IL-l/3 and TNFa,
while higher, were not significantly higher in endotoxin-positive
fluids. Uremia may be associated with detectable TNFa but not
IL-l/3 in plasma [29]. Those of our patients who were uremic
(Patients 1 to 3 and 6) had no greater frequency of IL-l/3 or
TNFa-positive cysts in their kidneys than did the nonuremic
subjects (Patients 4 and 5) (Fig. 1, A and B).
Flemodialysis certainly can be dismissed. The procedure can
increase TNFs levels and cause IL- 1/3 to appear in plasma [291.
However, only two of our 13 subjects were on hemodialysis
(Table 1), and each of them contributed only one to the total of
the 104 fluids available for study.
The results do not establish whether or how cytokines
influence the course of ADPKD. Several possibilities can be
considered: (i) Although IL-I /3 inhibits sodium reabsorption by
Fig. 5. IL-i 13 and sodium concentrations in
the same fluids. Concentrations vary
independently of one another across the span
of measured values. Symbols are: (U) IL-l/3
pg/mI; (LW) Na mEq/liter.
renal tubules [30, 31], we found no evidence that intralumenal
IL- 1/3 might play a role in the salt wasting that sometimes
accompanies cystic disease. Lack of any relationship between
IL-lp and sodium concentrations (Fig. 5) argues against the
possibility that IL-l/3 reduces sodium reabsorption across cyst
walls and accordingly plays a role in salt wasting. It argues, too,
against the possibility that cytokine concentrations vary among
cysts solely because the amounts of salt and water that are
reabsorbed vary from cyst to cyst (Fig. 1).
(ii) Since 12 of the 13 patients were symptomatic (Table 1)
and cytokines were present in some fluids from each of their
kidneys, it is possible that cytokines play a role in the pain of
polycystic kidney disease.
(iii) Individuals with ADPKD may inherit a defect in bodily or
intrarenal defenses that increases the susceptibility of their
kidneys to inflammation. Miller et al have demonstrated that
most urines from individuals with ADPKD test positively for
endotoxin [321, evidence that subjects with ADPKD may har-
bor latent infection, or may handle and excrete endotoxin
differently from normal individuals. Gabow, Inklerman and
Holmes [331 have shown that numbers of circulating neutrophils
are highest in subjects with proven, intermediate in subjects
with suspected, and lowest among individuals without ADPKD.
A similar relationship between renal pathology and neutrophilia
existed in our germfree rat model [15]. Neutrophilia is a
cytokine-mediated effect that is induced by lipopoiysaccharide
[31.
(iv) Cyst formation in polycystic kidneys might be a conse-
quence of cytokine-initiated, proteinase-mediated destruction
of segments of tubular basement membrane, Some of the higher
concentrations of IL-l/3 and TNFa that we measured in cysts
(Fig. 1) equal those found in rheumatoid synovial [lii and
meningitic spinal fluids [41. Stromelysin is active in the joint
remodeling that characterizes acute rheumatoid arthritis [13,
Number of samples
containing
IL-2 >0.1 ng/ml
Stromelysin >1.0 ng/ml
When interleukin- 1/3 in fluid was
Absent 0.1—19 pg/mI >20 pg/mI
1 of 10
0.1 0.1
4 of 8
6.8 4.3
2 of 4
0.3 0.2
4 of 4
8.9 2.6
Chi-square P..
3of7 6.507 <0.02
0.3 0.2 NSb
10 of 11 5.901 <0.05
12.1 5,6 NSb
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34]. It is a metalloproteinase capable of degrading collagen IV
and proteoglycan [35]. Collagen IV and proteoglycan are com-
ponents of renal tubular basement membrane [36]. A defect in
tubular basement membrane has long been included among
hypotheses to account for cyst development in polycystic
kidneys [36, 37]. By its presence in some cysts, stromelysin
might damage the integrity of tubular basement membrane and
favor cyst formation.
We conclude that symptomatic kidneys in ADPKD are sites
of cytokine accumulation and that cytokines are candidate
contributors to morbidity and pathogenesis in this heritable
disorder.
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